| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 1.530 | 0 | 0 | 0 | 0 | 4.605 |
| Total Income - EUR | - | - | 0 | 0 | 1.530 | 0 | 0 | 0 | 0 | 4.605 |
| Total Expenses - EUR | - | - | 6.955 | 6.260 | 6.716 | 5.131 | 288 | 175 | 0 | 5.258 |
| Gross Profit/Loss - EUR | - | - | -6.955 | -6.260 | -5.186 | -5.131 | -288 | -175 | 0 | -653 |
| Net Profit/Loss - EUR | - | - | -6.955 | -6.260 | -5.201 | -5.131 | -288 | -175 | 0 | -653 |
| Employees | - | - | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cazamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 67 | 66 | 65 | 63 | 62 | 62 | 62 | 62 |
| Current Assets | - | - | 785 | 1.174 | 3.784 | 2.677 | 2.633 | 2.669 | 3.577 | 11.400 |
| Inventories | - | - | 240 | 235 | 231 | 226 | 221 | 222 | 221 | 220 |
| Receivables | - | - | 322 | 708 | 2.390 | 3.231 | 3.213 | 3.256 | 3.247 | 8.626 |
| Cash | - | - | 224 | 230 | 1.163 | -780 | -802 | -809 | 109 | 2.554 |
| Shareholders Funds | - | - | -6.912 | -13.045 | -17.993 | -22.783 | -22.566 | -22.811 | -22.742 | -23.267 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 7.764 | 14.284 | 21.842 | 25.524 | 25.261 | 25.542 | 26.380 | 34.729 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Cazamed Srl